Seguir
John Teerlink
John Teerlink
San Francisco VA Medical Center/ University of California San Francisco
Dirección de correo verificada de ucsf.edu
Título
Citado por
Citado por
Año
HFSA 2010 comprehensive heart failure practice guideline.
J Lindenfeld, NM Albert, JP Boehmer, SP Collins, JA Ezekowitz, ...
Journal of cardiac failure 16 (6), e1-194, 2010
2610*2010
Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology …
B Bozkurt, AJS Coats, H Tsutsui, M Abdelhamid, S Adamopoulos, N Albert, ...
Journal of cardiac failure 27 (4), 387-413, 2021
14492021
Effect of nesiritide in patients with acute decompensated heart failure
CM O'Connor, RC Starling, AF Hernandez, PW Armstrong, K Dickstein, ...
New England Journal of Medicine 365 (1), 32-43, 2011
14352011
Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure
MR Costanzo, ME Guglin, MT Saltzberg, ML Jessup, BA Bart, JR Teerlink, ...
Journal of the American College of Cardiology 49 (6), 675-683, 2007
13512007
Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure
MR Costanzo, ME Guglin, MT Saltzberg, ML Jessup, BA Bart, JR Teerlink, ...
Journal of the American College of Cardiology 49 (6), 675-683, 2007
13512007
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
JR Teerlink, G Cotter, BA Davison, GM Felker, G Filippatos, ...
The Lancet 381 (9860), 29-39, 2013
10302013
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure
M Packer, JJV McMurray, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ...
Circulation 131 (1), 54-61, 2015
7782015
Warfarin and aspirin in patients with heart failure and sinus rhythm
S Homma, JLP Thompson, PM Pullicino, B Levin, RS Freudenberger, ...
New England Journal of Medicine 366 (20), 1859-1869, 2012
6562012
2017 cardiovascular and stroke endpoint definitions for clinical trials
KA Hicks, KW Mahaffey, R Mehran, SE Nissen, SD Wiviott, B Dunn, ...
Circulation 137 (9), 961-972, 2018
6052018
Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure
BM Massie, CM O'Connor, M Metra, P Ponikowski, JR Teerlink, G Cotter, ...
New England Journal of Medicine 363 (15), 1419-1428, 2010
5862010
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure
JR Teerlink, R Diaz, GM Felker, JJV McMurray, M Metra, SD Solomon, ...
New England Journal of Medicine 384 (2), 105-116, 2021
5182021
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes
M Metra, G Cotter, BA Davison, GM Felker, G Filippatos, BH Greenberg, ...
Journal of the American College of Cardiology 61 (2), 196-206, 2013
5112013
Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure
M Packer, W Colucci, L Fisher, BM Massie, JR Teerlink, J Young, ...
JACC: Heart Failure 1 (2), 103-111, 2013
5092013
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study
JR Teerlink, M Metra, GM Felker, P Ponikowski, AA Voors, BD Weatherley, ...
The Lancet 373 (9673), 1429-1439, 2009
5072009
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study
JR Teerlink, M Metra, GM Felker, P Ponikowski, AA Voors, BD Weatherley, ...
The Lancet 373 (9673), 1429-1439, 2009
5072009
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
AA Voors, CE Angermann, JR Teerlink, SP Collins, M Kosiborod, J Biegus, ...
Nature medicine 28 (3), 568-574, 2022
4742022
Developing therapies for heart failure with preserved ejection fraction: current state and future directions
J Butler, GC Fonarow, MR Zile, CS Lam, L Roessig, EB Schelbert, ...
JACC: Heart Failure 2 (2), 97-112, 2014
4582014
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials
JJV McMurray, JR Teerlink, G Cotter, RC Bourge, JGF Cleland, ...
Jama 298 (17), 2009-2019, 2007
3972007
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging …
JGF Cleland, JR Teerlink, R Senior, EM Nifontov, JJV Mc Murray, ...
The Lancet 378 (9792), 676-683, 2011
3892011
Diuretic response in acute heart failure: clinical characteristics and prognostic significance
MAE Valente, AA Voors, K Damman, DJ Van Veldhuisen, BM Massie, ...
European heart journal 35 (19), 1284-1293, 2014
3522014
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20